BioRestorative Therapies (BRTX) Cash from Financing Activities (2010 - 2026)
BioRestorative Therapies' Cash from Financing Activities was $4.44 million in Q1 2026, up 306.4% from $1.09 million a year earlier and up 381.0% from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Cash from Financing Activities (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, BioRestorative Therapies' Cash from Financing Activities was $6.2 million through Mar 31, 2026, up 550.5% year-over-year; for FY2025, it came in at $2.85 million, down 61.3% from FY2024.
- Cash from Financing Activities shows a five-year compound annual growth rate of -10.7% (FY2020 to FY2025).
- In earlier years, Cash from Financing Activities was $7.38 million in FY2024 (+214.2%), $2.35 million in FY2023 and $21.32 million in FY2021 (+324.1%).
- The Q1 2026 figure marks the highest quarterly Cash from Financing Activities since Q1 2024.
- Per Business Quant data, BRTX's Cash from Financing Activities in the three quarters before Q1 2026 was $923,243 (Q4 2025), -$49,308 (Q3 2025) and $888,138 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.51 Bn |
| 10 | BioRestorative Therapies | 1.36 Mn | -17.06 Mn | 15,785.00 | 4.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 4.44 Mn |
| Dec 31, 2025 | 923,243.00 |
| Sep 30, 2025 | -49,308.00 |
| Jun 30, 2025 | 888,138.00 |
| Mar 31, 2025 | 1.09 Mn |
| Dec 31, 2024 | -126,316.00 |
| Jun 30, 2024 | -12,843.00 |
| Mar 31, 2024 | 7.52 Mn |
| Dec 31, 2023 | 83,073.00 |
| Sep 30, 2023 | 1.85 Mn |
| Dec 31, 2021 | 21.07 Mn |
| Mar 31, 2021 | 250,000.00 |
| Dec 31, 2020 | 3.46 Mn |
| Sep 30, 2020 | 400,958.00 |
| Jun 30, 2020 | 713,755.00 |
| Mar 31, 2020 | 451,762.00 |
| Dec 31, 2019 | 1.71 Mn |
| Sep 30, 2019 | 531,333.00 |
| Jun 30, 2019 | 2.23 Mn |
| Mar 31, 2019 | 2.36 Mn |
API Access
BioRestorative Therapies Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();